Early cancer detection has an 80% survival rate, compared to less than 20% for late-stage cancer.- Statistics from the American Cancer Society
Cancer is a leading cause of death worldwide, and current detection methods are often inaccurate or invasive. Many people are diagnosed with cancer at a late stage, when treatment options are limited and outcomes are poor. We believe that early detection is key to improving cancer outcomes and saving lives.
Serenomica is a biotechnology company dedicated to developing innovative solutions for early cancer detection.
Our mission is to empower healthcare professionals and patients with accurate and reliable cancer detection tools.
We are passionate about providing a solution that offers a more holistic and complete view on the patient.
Your Cancer Risk Profile
Our comprehensive cancer detection and prevention solution, Serenomica One, brings together a range of advanced diagnostic tools and technologies to provide a comprehensive understanding of your health. This includes a combination of a comprehensive medical history check, minimally-invasive tests and imaging techniques that work together to detect signals of cancer, identify genetic risks, and personalize your treatment, empowering you to take control of your well-being.